Tisbury Pharmaceuticals' Series A Round

Tisbury Pharmaceuticals raised a round of funding on June 07, 2017.

Tisbury Pharmaceuticals is a pre-clinical stage pharmaceutical company focused on the discovery, development, and commercialization of groundbreaking therapy to treat primary open angle glaucoma. The …

Articles about Tisbury Pharmaceuticals' Series A Round: